PCI | tctmd.com

07:38

TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization

Presentation TCT 2020

TARGET FFR - Physiology-Guided Optimization of PCI: A Randomized Controlled Trial

Presenter: Damien Collison

October 16, 2020

Presentation TCT 2020

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Presenter: Manesh Patel

October 15, 2020

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Presentation TCT 2020

The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention

Presenter: Gregg Stone

October 14, 2020

11:57

Nightmare During Apparently Simple LCx PCI - Stent Embolization - Swati Sharma

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

By L.A. McKeown

September 24, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

By Yael L. Maxwell

September 14, 2020

Presentation Cardiovascular Interventions 2019

PCI Vs CABG for Multivessel and Unprotected LM Disease

Presenter: Paul S. Teirstein

November 01, 2019

Presentation Cardiovascular Interventions 2019

Approach to Bifurcation PCI: A Step By Step Refresher

Presenter: Curtiss T. Stinis

November 01, 2019

Subscribe to PCI

Advertisement

TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization

TARGET FFR - Physiology-Guided Optimization of PCI: A Randomized Controlled Trial

1-Year Outcomes of Patients with Residual Physiologic Ischemia After Percutaneous Coronary Intervention: The DEFINE PCI Trial

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention

Nightmare During Apparently Simple LCx PCI - Stent Embolization - Swati Sharma

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

PCI Vs CABG for Multivessel and Unprotected LM Disease

Approach to Bifurcation PCI: A Step By Step Refresher

Advertisement

TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization

Nightmare During Apparently Simple LCx PCI - Stent Embolization - Swati Sharma

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content